<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1683-9803</journal-id>
<journal-title><![CDATA[Pediatría (Asunción)]]></journal-title>
<abbrev-journal-title><![CDATA[Pediatr. (Asunción)]]></abbrev-journal-title>
<issn>1683-9803</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1683-98032026000200244</article-id>
<article-id pub-id-type="doi">10.31698/ped.53022026013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Paro cardiorespiratorio que podría estar asociado a uso de ondansetrón en un paciente pediátrico: caso clínico]]></article-title>
<article-title xml:lang="en"><![CDATA[Cardiorespiratory arrest potentially associated with ondansetron use in a pediatric patient: a case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Velandia Rodríguez]]></surname>
<given-names><![CDATA[Elver Fabian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Santacoloma]]></surname>
<given-names><![CDATA[Hernán Darío]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Agudelo]]></surname>
<given-names><![CDATA[Lorena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas Rodríguez]]></surname>
<given-names><![CDATA[Ledmar Jovanny]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gamboa Rodriguez]]></surname>
<given-names><![CDATA[Katherin Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital regional de la Orinoquia  ]]></institution>
<addr-line><![CDATA[Yopal ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2026</year>
</pub-date>
<volume>53</volume>
<numero>2</numero>
<fpage>244</fpage>
<lpage>248</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S1683-98032026000200244&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S1683-98032026000200244&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S1683-98032026000200244&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  El ondansetrón, un antagonista potente y selectivo de los receptores 5 hidroxitriptamina 3, por lo que ha sido utilizado como antiemético, y era considerado como un fármaco seguro por su baja tasa de efectos adversos, sin embargo, algunos estudios han demostrado que puede generar complicaciones severas. El objetivo del manuscrito es presentar el caso clínico de un paciente pediátrico que falleció por complicaciones relacionadas con el uso de ondasentron.  Caso clínico:  Paciente femenina de 11 meses de edad quien fue llevada por presentar intolerancia a la vía oral, emesis de gasto moderado y episodios diarreicos de 4 días de evolución asociado a deshidratación. Ante esto se decidió iniciar reposición de líquidos endovenosos y adicionalmente se administró única dosis de ondasentron, donde la paciente presentó paro cardiorespiratorio no reversible dos horas después. La autopsia clínica no reportó hallazgos relacionados al fallecimiento, sin embargo, no se descartó una posible arritmia relacionada con la administración del medicamento.  Conclusiones:  El ondansetrón es eficaz como antiemético y tiene un perfil de seguridad relativamente favorable, sin embargo, se justifica la conciencia de los distintos riesgos de su uso. Varios estudios han reportado que este fármaco presenta cardiotoxicidad, donde se han encontrado asociado a alteraciones electrolíticas, arritmias cardiacas e incluso paradas cardíacas. El caso llama la atención dado que ante un cuadro de diarrea y deshidratación en el que se había logrado controlar los demás factores, se trata de un ddiagnóstico que no es del todo contundente dado que los eventos cardíacos y arritmias suceden durante la administración del medicamento y no es común que suceda horas después. Una anamnesis es importante para estos casos, sin embargo, no hay un factor específico a tener presente, además un ECG inicial normal no garantiza una infusión segura de este fármaco.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Ondansetron is a potent and selective 5-hydroxytryptamine 3 (5-HT3) receptor antagonist widely used as an antiemetic and has generally been considered a safe medication because of its low rate of adverse effects. However, some studies have demonstrated that it may cause severe complications. The objective of this report is to present the clinical case of a pediatric patient who died from complications potentially related to ondansetron use.  Case Report:  An 11-month-old female patient was brought for evaluation because of oral intolerance, moderate-volume vomiting, and diarrhea for four days, associated with dehydration. Intravenous fluid replacement was initiated, and a single dose of ondansetron was administered. Two hours later, the patient experienced irreversible cardiorespiratory arrest. Clinical autopsy findings did not reveal abnormalities explaining the death; however, a possible arrhythmia associated with administration of the medication could not be ruled out.  Conclusions:  Ondansetron is effective as an antiemetic and has a relatively favorable safety profile; nevertheless, awareness of the potential risks associated with its use is warranted. Several studies have reported cardiotoxicity associated with this medication, including electrolyte abnormalities, cardiac arrhythmias, and even cardiac arrest. This case is noteworthy because, in the setting of diarrhea and dehydration in which other contributing factors had been addressed, the diagnosis of a medication-related cardiac event remains inconclusive, given the temporal relationship between medication administration and the subsequent cardiac event. A thorough medical history is important in such cases; however, there is no single specific risk factor that reliably predicts these events, and a normal baseline ECG does not guarantee safe administration of the medication.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Ondasentron]]></kwd>
<kwd lng="es"><![CDATA[muerte]]></kwd>
<kwd lng="es"><![CDATA[paro cardíaco]]></kwd>
<kwd lng="es"><![CDATA[corazón]]></kwd>
<kwd lng="en"><![CDATA[Ondansetron]]></kwd>
<kwd lng="en"><![CDATA[death]]></kwd>
<kwd lng="en"><![CDATA[cardiac arrest]]></kwd>
<kwd lng="en"><![CDATA[heart]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Wallisch]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Homanics]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting]]></article-title>
<source><![CDATA[Eur J Pharmacol]]></source>
<year>2014</year>
<volume>722</volume>
<page-range>55-66</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhong]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Shahbaz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Teskey]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Beever]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kachour]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Venketaraman]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of nausea and vomiting current knowledge and recent advances in intracellular emetic signaling systems]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2021</year>
<volume>22</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>5797</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bayat]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ryono]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Phelps]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Geis]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sedghi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Etminani]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduced mortality with ondansetron use in SARS-CoV-2-infected inpatients]]></article-title>
<source><![CDATA[Open Forum Infect Dis]]></source>
<year>2021</year>
<volume>8</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Wahib]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Support Care Cancer]]></source>
<year>2022</year>
<volume>30</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>8855-69</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[DY]]></given-names>
</name>
<name>
<surname><![CDATA[Trinh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Roy]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Torsades de pointes after ondansetron infusion in 2 patients]]></article-title>
<source><![CDATA[Tex Heart Inst J]]></source>
<year>2017</year>
<volume>44</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>366</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mamani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Eloy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paro cardiorrespiratorio presuntamente secundario a la administración de ondansetrón en paciente con trastorno electrolítico]]></article-title>
<source><![CDATA[Gac Med Bol]]></source>
<year>2022</year>
<volume>45</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>182-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kovac]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postoperative nausea and vomiting in pediatric patients]]></article-title>
<source><![CDATA[Paediatr Drugs]]></source>
<year>2021</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-37</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonvanie]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Weghorst]]></surname>
<given-names><![CDATA[AAH]]></given-names>
</name>
<name>
<surname><![CDATA[Holtman]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Russchen]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Fickweiler]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Verkade]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial.]]></article-title>
<source><![CDATA[Br J Gen Pract]]></source>
<year>2021</year>
<volume>71</volume>
<numero>711</numero>
<issue>711</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tricco]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Soobiah]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Blondal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Veroniki]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Vafaei]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis]]></article-title>
<source><![CDATA[BMC Med]]></source>
<year>2015</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tisdale]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Overholser]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Wroblewski]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Sowinski]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Amankwa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Borzak]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction]]></article-title>
<source><![CDATA[J Clin Pharmacol]]></source>
<year>2012</year>
<volume>52</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1296-305</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kulkarni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ganjare]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast a prospective single-blind randomised trial]]></article-title>
<source><![CDATA[Indian J Anaesth]]></source>
<year>2013</year>
<volume>57</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Pal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sarkar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mukherjee]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mitra]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Roy]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis]]></article-title>
<source><![CDATA[J Nat Sci Biol Med]]></source>
<year>2011</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>119</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Vo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Addo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Coralic]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of a single dose of intravenous ondansetron on QTc interval in emergency department patients]]></article-title>
<source><![CDATA[Am J Health Syst Pharm]]></source>
<year>2018</year>
<volume>75</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>276-82</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roden]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug-induced prolongation of the QT interval]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2004</year>
<volume>350</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1013-22</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freedman]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Uleryk]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rumantir]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Finkelstein]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ondansetron and the risk of cardiac arrhythmias a systematic review and postmarketing analysis]]></article-title>
<source><![CDATA[Ann Emerg Med]]></source>
<year>2014</year>
<volume>64</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Valerio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Knobloch]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potassium disorders: hypokalemia and hyperkalemia]]></article-title>
<source><![CDATA[Am Fam Physician]]></source>
<year>2023</year>
<volume>107</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Qu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Shivkumar]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Electrophysiology of hypokalemia and hyperkalemia]]></article-title>
<source><![CDATA[Circ Arrhythm Electrophysiol]]></source>
<year>2017</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
